NIAGEN BIOSCIENCE, INC. Long-term Debt, Gross
NIAGEN BIOSCIENCE, INC. (NAGE) had Long-term Debt, Gross of $10.12 million as of 2019-12-31, per its 10-K filed 2020-03-10.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2020-03-10
- 2019-12-31: Long-term Debt, Gross $10.12M.
- 2019-09-30: Long-term Debt, Gross $10.12M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2019-12-31 | $10.12M 10-K · filed 2020-03-10 |
| 2019-09-30 | $10.12M 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |